IGR Meeting : Improving Adoptive Cell Therapy
This event, organised by the Institut Gustave Roussy, will bring together the foremost experts in immunology, oncology, and cellular therapy.
Adoptive cell therapy, particularly CAR T-cell therapy, has marked a revolutionary milestone in the treatment of hematological malignancies and is now making strides in the realm of auto-immune diseases. However, for solid tumors, there remains a substantial path ahead.
This congress will delve into the critical aspects of optimizing adoptive cell therapy;
– The host conditions for greater efficacy of adoptive cell therapy.
– Focus on T-cell engineering, novel targets for CAR T-cell therapy.
Date : 30-31 May
Location : the Cordeliers Research Centre.
The meeting is designed to provide networking between clinicians, scientists from academic and industrial parterns in the field of cell therapies.
For those keen on diving deeper into biomanufacturing and gene delivery, we invite you to schedule a meeting with :
- Christine Duthoit, Chief Innovation Officer
- Alexandra Iché, Gene Engineering Project Manager
- Antoinette Crooke, Business Developper
- Patricia Canivenq, R&D Product Manager
Don’t miss this opportunity to be part of the dialogue driving forward the future of advanced therapies.
To register at this meeting : https://www.eventcreate.com/e/improving-adoptive-cell-therapy
About Flash BioSolutions:
Flash BioSolutions® is a preeminent CDMO specializing in the industrial-scale production of DNA and RNA vectors for clientele within the domains of gene and cell therapy, and vaccine development. Bolstered by a robust manufacturing platform and validated processes honed over two decades, Flash BioSolutions® excels in delivering vectors of unmatched purity and concentration across research, pre-clinical, clinical, and commercial phases.
Contact info
Contact
Head of communication
Soraya Sandokchi
+33 582 955 546